Get access

Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status

Authors

  • Nitin Saini,

    1. Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
    Search for more papers by this author
    • *Present address: Department of Cancer Biology, Kimmel Cancer Center, 233 South, BLSB Room No. 1008, Thomas Jefferson University, Philadelphia, PA 19107, USA.

  • Radhika Srinivasan,

    1. Department of Cytopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
    Search for more papers by this author
  • Yogesh Chawla,

    1. Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
    Search for more papers by this author
  • Sanjeev Sharma,

    1. Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
    Search for more papers by this author
  • Anuradha Chakraborti,

    1. Department of Experimental Medicine & Biotechnology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
    Search for more papers by this author
  • Arvind Rajwanshi

    1. Department of Cytopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, India
    Search for more papers by this author

Correspondence
Prof. Yogesh Chawla, Department of Hepatology, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India
Tel: +91 172 2756339
Fax: +91 172 2744401
e-mail: nitin3112k@yahoo.com

Abstract

Background: Telomerase expression and the maintenance of a critical telomere length (TL) in cancer initiation indicates that telomere shortening and telomerase expression initiates cancer by induction of chromosomal instability.

Methods: Telomerase activity, TL and human telomerase reverse transcriptase (hTERT) expression were investigated in 58 hepatocellular carcinoma (HCC) and 17 chronic hepatitis patients by the telomerase repeat amplification protocol, Southern blotting and reverse transcriptase-polymerase chain reaction.

Results: Telomerase was positive in 76% of HCC and 11.8% of chronic hepatitis patients (P<0.0001). The mean telomere length (MTL) in HCC was significantly shorter compared with chronic hepatitis (P<0.0001). The MTL was not significantly different in HCC patients with and without cirrhosis (P=0.77). In hepatitis B virus, hepatitis C virus and non-B non-C-related HCC groups, no differences were found in telomerase activity and MTL (P=0.77). hTERT, a regulator of telomerase, was, however, positive in 81% of HCCs. The correlation between telomerase activity and hTERT mRNA expression was statistically significant (P<0.0001). The MTL in telomerase-positive HCC cases was significantly shorter than the MTL in telomerase-negative cases (P<0.0001).

Conclusion: The majority of HCCs exhibited telomerase activity that correlated well with hTERT expression. MTL in HCC was significantly shorter than chronic hepatitis. It was also found that shorter telomeres are present in telomerase-positive HCC cases. However, no correlation was found between telomerase activity and TL with respect to the viral status in HCC.

Ancillary